Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Dimethylamino parthenolide (DMAPT) is an inhibitor of NF-κB and a derivative of parthenolide (Item No. 70080).1 It inhibits the binding of the p65 subunit of NF-κB to DNA by 75% when used at a concentration of 50 µM. DMAPT (25 µM) decreases intracellular glutathione (GSH) levels in, and inhibits the migration of, MDA-MB-231 breast cancer cells. It induces necrosis in MDA-MB-231 cells, an effect that can be reversed by the antioxidant N-acetyl cysteine (Item No. 20261), NADPH oxidase inhibitor apocynin (Item No. 11976), or RIP1 kinase inhibitor necrostatin-1 (Item No. 11658). DMAPT (50 mg/kg) decreases tumor volume in an MDA-MB-231 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Parthenolide generates reactive oxygen species and autophagy in MDA-